Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Registration Number
- NCT02489968
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
Two independent study parts (i.e. Part A and Part B) are included in this trial. Part A will evaluate empagliflozin 10 mg + linagliptin and Part B will evaluate empagliflozin 25 mg + linagliptin. All analyses will be carried out separately for these study parts. The objective of Part A is to investigate the efficacy, safety and tolerability of the fixed dose combination (FDC) of empagliflozin 10 mg / linagliptin 5 mg compared with empagliflozin 10 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM (Type 2 Diabetes Mellitus) who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 10 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 10 mg / linagliptin 5 mg over empagliflozin 10 mg plus FDC matching placebo after 24 weeks of treatment. The objective of Part B is to investigate the efficacy, safety and tolerability of the FDC of empagliflozin 25 mg / linagliptin 5 mg compared with empagliflozin 25 mg plus FDC matching placebo administered orally once daily for 24 weeks in Japanese patients with T2DM who have insufficient glycaemic control after 16 weeks of treatment with empagliflozin 25 mg alone once daily. The study is designed to show superiority of the FDC of empagliflozin 25 mg / linagliptin 5 mg over empagliflozin 25 mg plus FDC matching placebo after 24 weeks of treatment. The 24 week treatment period will be followed by a 28 week extension treatment period to evaluate further efficacy and safety up to 52 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 880
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description empagliflozin 10 mg + linagliptin 5 mg empagliflozin 10 mg + linagliptin 5 mg patient to receive a tablet containing low dose empagliflozin and linagliptin once daily empagliflozin 25 mg + linagliptin 5 mg empagliflozin 25 mg + linagliptin 5 mg patient to receive a tablet containing high dose empagliflozin and linagliptin once daily empagliflozin 10 mg empagliflozin 10 mg patient to receive a tablet containing low dose empagliflozin once daily empagliflozin 25 mg empagliflozin 25 mg patients to receive a tablet containing high dose empagliflozin once daily empagliflozin 10 mg Placebo patient to receive a tablet containing low dose empagliflozin once daily empagliflozin 25 mg Placebo patients to receive a tablet containing high dose empagliflozin once daily
- Primary Outcome Measures
Name Time Method Change in Glycated Haemoglobin A1c (HbA1c) (%) From Baseline After 24 Weeks of Treatment Baseline and 24 week Change from baseline in HbA1c (%) after 24 weeks of treatment with double-blind trial medication. Change was calculated as: HbA1c value at 24-week - HbA1c value at baseline, for each patient. Baseline was defined as the last observation before the first intake of double-blind randomised trial medication. Statistical analysis presented is based on a restricted maximum likelihood (REML)-based mixed model repeated measures (MMRM) approach. Full Analysis Set (Observed Cases) \[FAS (OC)\]: This analysis set consisted of all patients who were randomised and treated with at least 1 dose of trial drug during the double-blind part of the trial and who had a baseline HbA1c assessment and at least 1 on-treatment HbA1c assessment during the 24-week double-blind part of the trial. Observed cases analysis included only the available data that were observed while patients were on treatment, i.e., excluding the missing data.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (83)
Ebetsu Internal Medicine Clinic
๐ฏ๐ตHokkaido, Ebetsu, Japan
Iida Medical Clinic
๐ฏ๐ตHokkaido, Hakodate, Japan
Morinagaueno clinic, Kumamoto, Digestive Tract I.M.
๐ฏ๐ตKumamoto, Kumamoto, Japan
AGE Makita Medical Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Kanda Clinic, Tokyo, I.M.
๐ฏ๐ตTokyo, Japan
Shin Yukuhashi Hospital
๐ฏ๐ตFukuoka, Yukuhashi, Japan
Odayaka Life Naika Clinic, Saitama, I.M.
๐ฏ๐ตSaitama, Koshigaya, Japan
Hamamatsu Rosai Hospital
๐ฏ๐ตShizuoka, Hamamatsu, Japan
Nihonbashi Sakura Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Fukuwa Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Kikuchi Naika Clinic, Gunma, I.M.
๐ฏ๐ตGunma, Maebashi, Japan
Manda Memorial Hospital
๐ฏ๐ตHokkaido, Sapporo, Japan
Japan Community Health Care Organization Hokkaido Hospital
๐ฏ๐ตHokkaido, Sapporo, Japan
Kumamoto University Hospital
๐ฏ๐ตKumamoto, Kumamoto, Japan
Clinic Sugiyama, Yamagata, I.M.
๐ฏ๐ตYamagata, Yamagata, Japan
Tokai Memorial Hospital
๐ฏ๐ตAichi, Kasugai, Japan
Japan Organization of Occupational Health and Safety Chubu Rosai Hospital
๐ฏ๐ตAichi, Nagoya, Japan
Kunisaki Makoto Clinic, Fukuoka, I.M./CV Med.
๐ฏ๐ตFukuoka, Fukuoka, Japan
Fukuoka Shin Mizumaki Hospital
๐ฏ๐ตFukuoka, Onga, Japan
Hashimoto I.M., Gifu, I.M.
๐ฏ๐ตGifu, Gifu, Japan
Hasegawa Internal Medicine Clinic
๐ฏ๐ตHokkaido, Chitose, Japan
Honda Hidehiko Clinic
๐ฏ๐ตTokyo, Ota-ku, Japan
Murakami Memorial Hp., Ehime, I.M.
๐ฏ๐ตEhime, Saijo, Japan
Hakodate Koseiin Hakodate Central General Hospital
๐ฏ๐ตHokkaido, Hakodate, Japan
Uehara Clinic
๐ฏ๐ตHokkaido, Sapporo, Japan
Namegata District General Hospital
๐ฏ๐ตIbaraki, Namegata, Japan
Oikawa Clinic
๐ฏ๐ตIwate, Morioka, Japan
Hirano Medical Clinic
๐ฏ๐ตIwate, Morioka, Japan
Tokuyama Clinic
๐ฏ๐ตChiba, Chiba, Japan
Tanaka Int. Clinic, Ehime, DIA Med.,CV Med.
๐ฏ๐ตEhime, Niihama, Japan
Kurihara Clinic
๐ฏ๐ตHokkaido, Sapporo, Japan
Sapporo Diabetes, Thyroid Clinic
๐ฏ๐ตHokkaido, Sapporo, Japan
Hokuriku Hp., Ishikawa, I.M.
๐ฏ๐ตIshikawa, Kanazawa, Japan
Ashiya Municipal Hospital
๐ฏ๐ตHyogo, Ashiya, Japan
Itabashi DIA Med. and DERM Clinic, Ibaraki, I.M.
๐ฏ๐ตIbaraki, Koga, Japan
Takai Naika Clinic
๐ฏ๐ตKanagawa, Kamakura, Japan
Nagatsuta Family Clinic, Kanagawa, I.M.
๐ฏ๐ตKanagawa, Yokohama, Japan
Jinnouchi Clinic Diabetes Care Center
๐ฏ๐ตKumamoto, Kumamoto, Japan
Iwamoto Clinic, Kagawa, DIAB I.M.
๐ฏ๐ตKagawa, Zentsuji, Japan
Tenpozan Clinic of I.M., Kagoshima, I.M.
๐ฏ๐ตKagoshima, Kagoshima, Japan
Hayashi DIA Clinic, Kanagawa, DIA Tract Med.ยทI.M.
๐ฏ๐ตKanagawa, Chigasaki, Japan
Motomachi Takatsuka Naika Clinic, Kanagawa, I.M.
๐ฏ๐ตKanagawa, Yokohama, Japan
Kajiyama Clinic, Kyoto, I.M.
๐ฏ๐ตKyoto, Kyoto, Japan
Matsumoto Nakagawa Hospital
๐ฏ๐ตNagano, Matsumoto, Japan
Saiseikai Niigata Daini Hp., Niigata, METAB ENDO
๐ฏ๐ตNiigata, Niigata, Japan
Tsuyama Chuo Hospital
๐ฏ๐ตOkayama, Tsuyama, Japan
Yokohama Minoru Clinic
๐ฏ๐ตKanagawa, Yokohama, Japan
Ota DIA I.M. Clinic, Nagano, I.M.
๐ฏ๐ตNagano, Nagano, Japan
Nanko Clinic, Osaka, I.M.
๐ฏ๐ตOsaka, Osaka, Japan
Yaesu Clinic, Okinawa, I.M.
๐ฏ๐ตOkinawa, Naha, Japan
Tanaka Clinic, Okinawa, I.M.
๐ฏ๐ตOkinawa, Tomigusuku, Japan
Umeda Oak Clinic, Osaka, I.M.
๐ฏ๐ตOsaka, Osaka, Japan
Ikeoka Clinic, Osaka, I.M.
๐ฏ๐ตOsaka, Osaka, Japan
Shiraiwa Medical Clinic, Osaka, I.M.
๐ฏ๐ตOsaka, Japan
Medical corporation Chisei-kai Watanabe clinic
๐ฏ๐ตSaitama, Okegawa, Japan
Kinugawa CARDIOL Clinic, Osaka, I.M.
๐ฏ๐ตOsaka, Osaka, Japan
OCROM Clinic
๐ฏ๐ตOsaka, Suita, Japan
AMC Nishi-umeda Clinic
๐ฏ๐ตOsaka, Japan
Saga Memorial Hospital
๐ฏ๐ตSaga, Saga, Japan
SAINO Clinic,
๐ฏ๐ตSaitama, Tokorozawa, Japan
Shinkoiwa Ekimae Sougou Clinic
๐ฏ๐ตTokyo, Katushika-ku, Japan
Plumeria Clinic, Shizuoka, I.M.
๐ฏ๐ตShizuoka, Shizuoka, Japan
Wakakusa Clinic, Tochigi, I.M.
๐ฏ๐ตTochigi, Shimotsuke, Japan
Nihonbashi Enomoto Internal Medicine
๐ฏ๐ตTokyo, Chuo-ku, Japan
New Medical Research System Clinic
๐ฏ๐ตTokyo, Hachioji, Japan
Medical Corporation Keikokai P1-Clinic
๐ฏ๐ตTokyo, Hachioji, Japan
Minamino Heart Clinic
๐ฏ๐ตTokyo, Hachioji, Japan
Hosono Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Shinagawa East one Medical Clinic
๐ฏ๐ตTokyo, Minato-ku, Japan
Kasai Diabetes Clinic
๐ฏ๐ตTokyo, Edogawa-ku, Japan
Musashino Polyclinic
๐ฏ๐ตTokyo, Kiyose, Japan
Miho Clinic
๐ฏ๐ตTokyo, Shinagawa-ku, Japan
Shimamura Kinen Hospital
๐ฏ๐ตTokyo, Nerima-ku, Japan
Kenkoukan Suzuki Clinic
๐ฏ๐ตTokyo, Ota-ku, Japan
Sakayori Clinic
๐ฏ๐ตTokyo, Shinagawa-ku, Japan
ToCROM Clinic
๐ฏ๐ตTokyo, Shinjuku-ku, Japan
Ikebukuro Metropolitan Clinic
๐ฏ๐ตTokyo, Toshima-ku, Japan
Fujikoshi Hp., Toyama, I.M.
๐ฏ๐ตToyama, Toyama, Japan
Matsuyama Shimin Hospital
๐ฏ๐ตEhime, Matsuyama, Japan
Medical Corporation Toujinkai Sakado Central Hospital
๐ฏ๐ตSaitama, Sakado, Japan
Tokyo-Eki Center-building Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Tokyo Center Clinic
๐ฏ๐ตTokyo, Chuo-ku, Japan
Pedi Shiodome Clinic
๐ฏ๐ตTokyo, Minato-ku, Japan